Cambridge Trust Co. Has $2.93 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Cambridge Trust Co. lowered its stake in CVS Health Co. (NYSE:CVS - Free Report) by 32.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 37,045 shares of the pharmacy operator's stock after selling 17,571 shares during the quarter. Cambridge Trust Co.'s holdings in CVS Health were worth $2,925,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Live Oak Investment Partners acquired a new position in CVS Health in the 4th quarter valued at $25,000. Atticus Wealth Management LLC raised its holdings in CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator's stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. Cornerstone Planning Group LLC raised its holdings in CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 243 shares during the last quarter. ZRC Wealth Management LLC raised its holdings in CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator's stock valued at $39,000 after acquiring an additional 400 shares during the last quarter. Finally, True Wealth Design LLC acquired a new position in CVS Health in the 4th quarter valued at $48,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CVS. SVB Leerink began coverage on CVS Health in a report on Monday, February 26th. They set an "outperform" rating and a $88.00 price objective for the company. Barclays began coverage on CVS Health in a report on Wednesday, March 6th. They set an "equal weight" rating and a $78.00 price objective for the company. Wells Fargo & Company dropped their price objective on CVS Health from $83.00 to $76.00 and set an "equal weight" rating for the company in a report on Monday, April 8th. Royal Bank of Canada dropped their price objective on CVS Health from $86.00 to $84.00 and set an "outperform" rating for the company in a report on Thursday, February 8th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $87.00 price objective on shares of CVS Health in a report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average price target of $89.44.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of the firm's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is currently owned by insiders.

CVS Health Stock Up 1.2 %

NYSE:CVS traded up $0.79 on Thursday, reaching $69.39. The stock had a trading volume of 10,064,442 shares, compared to its average volume of 10,895,185. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company has a 50-day moving average of $75.53 and a 200 day moving average of $73.73. The stock has a market cap of $87.46 billion, a P/E ratio of 10.71, a price-to-earnings-growth ratio of 0.91 and a beta of 0.52. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion for the quarter, compared to analysts' expectations of $90.58 billion. During the same quarter last year, the company posted $1.99 earnings per share. The company's quarterly revenue was up 11.9% compared to the same quarter last year. On average, research analysts predict that CVS Health Co. will post 8.32 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.83%. CVS Health's dividend payout ratio is presently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.